PDT Partners’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

PDT Partners’s Portfolio GTHX Stock Details GTHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,387	Closed	-$51K	–	855
2024 Q2	$51K	Hold	22,387	–	–	﹤0.01%	651
2024 Q1	$96.7K	Buy	+22,387	New	+$78K	0.01%	607
2022 Q4	–	Sell	-45,605	Closed	-$570K	–	938
2022 Q3	$570K	Sell	45,605 -33,932	-43%	-$388K	0.09%	404
2022 Q2	$393K	Buy	+79,537	New	+$440K	0.03%	669
2021 Q3	–	Sell	-51,094	Closed	-$1.12M	–	941
2021 Q2	$1.12M	Sell	51,094 -41,312	-45%	-$918K	0.07%	356
2021 Q1	$2.22M	Sell	92,406 -6,319	-6%	-$147K	0.16%	249
2020 Q4	$1.78M	Sell	98,725 -41,199	-29%	-$616K	0.12%	259
2020 Q3	$1.62M	Buy	139,924 +99,005	+242%	+$1.63M	0.11%	241
2020 Q2	$993K	Buy	+40,919	New	+$677K	0.07%	286

PDT Partners's GTHX Position: Q3 2024 in Review

PDT Partners sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q3 2024, closing a stake of 22,387 shares — an estimated $51K sold.

PDT Partners first reported a position in GTHX in Q2 2020 and held it in 9 quarters. The position peaked at $2.22M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTHX as of Q3 2024.

PDT Partners reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
PDT Partners sold 22,387 G1 Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $51K.
PDT Partners first reported a position in G1 Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
PDT Partners's G1 Therapeutics, Inc. Common Stock position peaked at $2.22M in Q1 2021.
0 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q3 2024.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.